Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...

Following a series of Middle East investments in key therapeutic areas aligned with both patient needs and market demands ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

Facing steep competition, Novo Nordisk has slashed the price for its weight loss drug Wegovy — temporarily, at least.

Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio ...

Hyderabad: Shilpa Medicare Limited, a pharmaceutical and biotechnology company, has announced that its 100 percent subsidiary ...

Indias corporate earnings season is approaching its final stretch as the last week of May 2025 gears up to deliver over 1,500 ...

Deputy Chief Secretary Warner Cheuk says plan part of effort to offer visitors experiences beyond traditional shopping, ...

This leads to relatively smooth (though not flawless) northbound trajectories and strong returns for most stocks over a ...

On another issue, President Trump signed the Take It Down Act, which targets revenge porn and deepfakes. While it can be ...

According to the company, 19 new products were introduced in 2022, followed by 11 in 2023 and another 14 in 2024. For ...